Rogério Vivaldi Coelho
Vorstandsvorsitzender bei SIGILON THERAPEUTICS, INC.
Vermögen: 465 190 $ am 31.07.2023
Aktive Positionen von Rogério Vivaldi Coelho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIGILON THERAPEUTICS, INC. | Vorstandsvorsitzender | 14.08.2018 | - |
Direktor/Vorstandsmitglied | 14.08.2018 | 11.08.2023 | |
Finanzdirektor/CFO | - | 18.02.2022 | |
Präsident | 14.08.2018 | 11.08.2023 | |
CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 03.01.2022 | - |
Independent Dir/Board Member | 03.01.2022 | - |
Karriereverlauf von Rogério Vivaldi Coelho
Ehemalige bekannte Positionen von Rogério Vivaldi Coelho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOVERATIV INC | Corporate Officer/Principal | 01.01.2016 | 01.01.2018 |
SPARK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2014 | 05.01.2015 |
Independent Dir/Board Member | 01.04.2014 | 05.01.2015 | |
Corporate Officer/Principal | 01.04.2014 | 01.01.2016 | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.1997 | - |
MINERVA NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 23.04.2007 | 05.11.2014 |
Vorstandsvorsitzender | 23.04.2007 | 20.11.2014 | |
Gründer | 23.04.2007 | 20.11.2014 | |
Präsident | 23.04.2007 | 05.11.2014 | |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | 20.11.2014 |
Ausbildung von Rogério Vivaldi Coelho
Federal University of Rio de Janeiro | Doctorate Degree |
COPPEAD Graduate School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Brasilien | 3 |
Schweiz | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MINERVA NEUROSCIENCES, INC. | Health Technology |
SIGILON THERAPEUTICS, INC. | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Health Services |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Rogério Vivaldi Coelho
- Erfahrung